Latest S-1 registration statements

Snail, Inc. files an S-1 registration statement to allow selling stockholders to resell 5.4 million Class A common shares converted from recent private placement notes, following a period of revenue decline and net losses.

Amatuhi Holdings, Inc. filed an amendment to its S-1 registration statement solely to update the consent of its independent registered public accounting firm, Assentsure PAC.

Buda Juice, LLC is converting to a Delaware corporation and launching its initial public offering of 2,666,667 shares of common stock, aiming to expand its UltraFresh juice category nationally.

GeoVax Labs, a clinical-stage biotechnology company, is offering up to $7.5 million in common and pre-funded units to fund operations, facing a 'going concern' opinion and recent contract termination.

Heritage Distilling Holding Company, Inc. (IPST) reports a significant net income of $185.9 million for the nine months ended September 30, 2025, driven by a new cryptocurrency treasury strategy and $IP Token valuation gains, while restructuring its craft spirits business.

NUBURU, Inc. filed an S-1 registration statement for the resale of up to 130 million common shares by a selling stockholder, aiming to fund its Transformation Plan and recent strategic acquisitions despite ongoing financial losses and NYSE non-compliance.

Nocera, Inc. filed an S-1/A registration statement for the resale of up to 45,000,000 shares of common stock by a selling stockholder, convertible from Series B Preferred Stock, with no direct proceeds to the company from these sales.

Pineapple Financial Inc. reports improved net loss and revenue growth for fiscal year 2025, while embarking on a new digital asset treasury strategy and addressing significant liquidity concerns.

Actelis Networks, Inc. announces a best-efforts public offering of common stock and warrants to raise up to $5 million for general corporate purposes, alongside details of recent financing activities and ongoing Nasdaq compliance.

Antiaging Quantum Living Inc. registers 4.28 million Class A Common Stock shares for resale by selling stockholders, following debt conversion, as it expands PRC operations despite recurring losses and going concern doubts.

Revium Rx, a preclinical biotech firm, is launching a self-underwritten IPO to fund its lipid-based therapies, while facing delays in its lead drug candidates and a dispute over a critical license option.

Alpha One Inc. reports a significant 97% revenue decrease and substantial net loss for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.

Bimergen Energy Corporation, a renewable energy project developer, filed an S-1/A registration statement for a public offering of common stock and warrants, seeking to raise $10.6 million to fund its BESS and solar project development and secure a NYSE American listing.

Osprey Bitcoin Trust files an amended registration statement to convert to an exchange-traded product, detailing recent financial performance and operational updates.

Legence Corp. filed an S-1MEF to register 1,612,504 additional Class A common stock shares for its ongoing public offering, including underwriters' option.

AIM ImmunoTech Inc. is conducting a non-transferable subscription rights offering to raise up to $12 million by selling units consisting of Series G Convertible Preferred Stock and Warrants.

Shuttle Pharmaceuticals Holdings, Inc. is registering shares for resale by a selling stockholder following a strategic pivot to AI-driven drug discovery and the discontinuance of its lead clinical program.

Beyond Air, Inc. filed an S-1/A registration statement for the potential resale of up to 1,600,000 common shares by Streeterville Capital, LLC, stemming from a $20 million equity purchase agreement.

JFB Construction Holdings files an S-1/A for the resale of up to 24,852,314 shares of common stock by selling stockholders, with no direct proceeds to the company from the sale.

Alpha Modus Holdings, Inc. files an S-1 registration statement for the resale of up to 11.29 million common shares and 8.83 million warrants, while facing significant financial challenges including recurring losses and a going concern qualification.

Maison Solutions Inc. filed an S-1 registration statement for the resale of up to 16.9 million Class A common shares by a selling stockholder, stemming from a secured convertible note and highlighting significant dilution risks and Nasdaq compliance challenges.

Society Pass Incorporated is offering up to 2,054,794 shares of common stock and pre-funded warrants to raise approximately $2.625 million for working capital and general corporate purposes, despite a going concern opinion.

SRx Health Solutions, Inc. is undergoing a significant transformation, divesting its Canadian healthcare operations to focus on its Halo pet health and wellness business, while securing substantial financing through an Equity Line of Credit.

Bonk, Inc. filed an S-1 registration statement for the resale of up to 31,839,533 shares of common stock by selling stockholders, following a strategic shift to digital assets and recent corporate restructuring.

Lion Copper and Gold Corp. filed an S-1/A registration statement for the resale of up to 250,344,126 common shares by selling shareholders, including shares underlying outstanding debentures and warrants.

Azitra, Inc. files an S-1 registration statement for the resale of over 51 million shares by selling stockholders, including those from recent capital raises, while facing NYSE American minimum equity non-compliance.

Actelis Networks, Inc. filed an S-1/A registration statement for the resale of up to 680,422 shares of common stock by selling stockholders, following recent capital raises and Nasdaq compliance efforts.

K2 Capital Acquisition Corporation, a newly formed SPAC, is launching a $100 million IPO to target business combinations in humanoid robotics, physical AI, and small modular nuclear reactors.

ARC Group Acquisition I Corp, a blank check company, filed an S-1/A for its initial public offering of 15 million units, each comprising one Class A ordinary share and one-half of a redeemable warrant, aiming to raise $150 million for a business combination.

GRI Bio, Inc. amended its engagement agreement with H.C. Wainwright & Co., LLC, extending the term for capital raising activities and removing the right of first refusal.